Complications associated with cardiac resynchronization therapy upgrades versus de novo implantations

References

• Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;2016 Aug;18(8):891–975. PubMed PMID: 27207191; eng.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2013; ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15. 6216:e147–239. PubMed PMID: 23747642; eng.
   PubMed Web of Science ®Google Scholar
• Sohaib SM, Finegold JA, Nijjer SS, et al. Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials. JACC Heart failure. 2015; Apr;3(4):327–336. PubMed PMID: 25770400; eng.
   PubMed Web of Science ®Google Scholar
• Rinaldi CA, Burri H, Thibault B, et al. A review of multisite pacing to achieve cardiac resynchronization therapy. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2015; Jan;17(1):7–17. PubMed PMID: 25214507; eng.
   PubMed Web of Science ®Google Scholar
• Lindvall C, Na C, Chang Y, et al. National trends in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator. Circulation. 2016; Jan;19;133(3):273–281. PubMed PMID: 26635400; PubMed Central PMCID: PMCPMC5259807. eng.
   PubMed Web of Science ®Google Scholar
• Raatikainen MJ, Arnar DO, Zeppenfeld K, et al. Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2015; Jan;17 Suppl 1:i1–75. PubMed PMID: 25616426; eng.
   Google Scholar
• Bogale N, Witte K, Priori S, et al. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. Eur J Heart Fail. 2011; Sep;13(9):974–983. PubMed PMID: 21771823; eng.
   PubMed Web of Science ®Google Scholar
• Vamos M, Erath JW, Bari Z, et al. Effects of upgrade versus de novo cardiac resynchronization therapy on clinical response and long-term survival: results from a multicenter study. Circulation Arrhythmia and electrophysiology. 2017; Feb;10(2):e004471. PubMed PMID: 28202628; eng.
   PubMed Web of Science ®Google Scholar
• Linde CM, Normand C, Bogale N, et al. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II. Eur J Heart Fail. 2018; May;27; PubMed PMID: 29806208; eng. DOI:10.1002/ejhf.1235.
   Google Scholar
• Cleland JG, Abraham WT, Linde C, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013; Dec;34(46):3547–3556. PubMed PMID: 23900696; PubMed Central PMCID: PMCPMC3855551. eng.
   PubMed Web of Science ®Google Scholar
• Sipahi I, Carrigan TP, Rowland DY, et al. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med. 2011; Sep;12;171(16):1454–1462. PubMed PMID: 21670335; eng.
   PubMedGoogle Scholar
• Ter Horst IA, Kuijpers Y, Van ‘T Sant J, et al. Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations? A single centre experience. Neth heart journal: monthly journal Neth Soc Cardiol Neth Heart Found. 2016; Jan;24(1):75–81. PubMed PMID: 26643305; PubMed Central PMCID: PMCPMC4692830. eng.
   Google Scholar
• Gould J, Sieniewicz B, Porter B, et al. Chronic right ventricular pacing in the heart Failure population. Curr Heart Fail Rep. 2018; Feb:12; 10.1007/s11897–018–0376-x. PubMed PMID: 29435789; eng.
   Google Scholar
• Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003; Jun;17;107(23):2932–2937. PubMed PMID: 12782566; eng.
   PubMed Web of Science ®Google Scholar
• Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med. 2013; Apr;25;368(17):1585–1593. PubMed PMID: 23614585; eng.
   PubMed Web of Science ®Google Scholar
•  Blanc JJ, Funck RC, Lunati M, et al. BioPace trial investigators and coordinators biventricular pacing for atrio-ventricular block to prevent cardiac desynchronization. 2014.
   Google Scholar
• Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart rhythm. 2017; Dec;14(12):e503–e551. PubMed PMID: 28919379; eng.
   PubMed Web of Science ®Google Scholar
• Kolek MJ, Dresen WF, Wells QS, et al. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing and clinical electrophysiology: PACE. 2013; Mar;36(3):354–361. PubMed PMID: 23252988; PubMed Central PMCID: PMCPMC3949624. eng.
   PubMed Web of Science ®Google Scholar
• Sidhu BS, Gould J, Sieniewicz B, et al. The role of transvenous lead extraction in the management of redundant or malfunctioning pacemaker and defibrillator leads post ELECTRa. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2018; Feb;14; PubMed PMID: 29452360; eng. DOI:10.1093/europace/euy018.
   Google Scholar
• Haghjoo M, Nikoo MH, Fazelifar AF, et al. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2007; May;9(5):328–332. PubMed PMID: 17369270; eng.
   PubMed Web of Science ®Google Scholar
• Sohal M, Williams S, Akhtar M, et al. Laser lead extraction to facilitate cardiac implantable electronic device upgrade and revision in the presence of central venous obstruction. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2014; Jan;16(1):81–87. PubMed PMID: 23794614; PubMed Central PMCID: PMCPMC3864757. eng.
   PubMed Web of Science ®Google Scholar
• Al-Majed NS, McAlister FA, Bakal JA, et al. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med. 2011; Mar;15;154(6):401–412. PubMed PMID: 21320922; eng.
   PubMed Web of Science ®Google Scholar
• Foley PW, Muhyaldeen SA, Chalil S, et al. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2009; Apr;11(4):495–501. PubMed PMID: 19307283; eng.
   PubMed Web of Science ®Google Scholar
• Duray GZ, Israel CW, Pajitnev D, et al. Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2008; Jan;10(1):48–52. PubMed PMID: 18077483; eng.
   PubMed Web of Science ®Google Scholar
• Cheung JW, Ip JE, Markowitz SM, et al. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: a comparative analysis using a United States National Database 2003–2013. Heart rhythm. 2017; Jul;14(7):1043–1050. PubMed PMID: 28214565; eng.
   PubMed Web of Science ®Google Scholar
• Kosztin A, Vamos M, Aradi D, et al. De novo implantation vs. upgrade cardiac resynchronization therapy: a systematic review and meta-analysis. Heart Fail Rev. 2018; Jan;23(1):15–26. 10.1007/s10741–017–9652–1. PubMed PMID: 29047028; PubMed Central PMCID: PMCPMC5756552. eng.
   PubMed Web of Science ®Google Scholar
• Kirkfeldt RE, Johansen JB, Nohr EA, et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014; May;35(18):1186–1194. PubMed PMID: 24347317; PubMed Central PMCID: PMCPMC4012708. eng.
   PubMed Web of Science ®Google Scholar
• Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010; Oct;19;122(16):1553–1561. PubMed PMID: 20921437; eng.
   PubMed Web of Science ®Google Scholar
• Essebag V, Joza J, Birnie DH, et al. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy. Circulation Arrhythmia and electrophysiology. 2015; Feb;8(1):152–158. PubMed PMID: 25417892; eng.
   PubMed Web of Science ®Google Scholar
• Palmisano P, Accogli M, Zaccaria M, et al. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2013; Apr;15(4):531–540. PubMed PMID: 23407627; eng.
   PubMed Web of Science ®Google Scholar
• Johansen JB, Jorgensen OD, Moller M, et al. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J. 2011; Apr;32(8):991–998. PubMed PMID: 21252172; PubMed Central PMCID: PMCPMC3076667. eng.
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Gleva MJ, Warren DK, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry. Pacing and clinical electrophysiology: PACE. 2012; Jan;35(1):81–87. PubMed PMID: 22077194; eng.
   PubMed Web of Science ®Google Scholar
• Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2015; May;17(5):767–777. . PubMed PMID: 25926473; eng.
   PubMed Web of Science ®Google Scholar
• Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007; Sep;18;116(12):1349–1355. PubMed PMID: 17724263; eng.
   PubMed Web of Science ®Google Scholar
• Nery PB, Fernandes R, Nair GM, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol. 2010; Jul;21(7):786–790. PubMed PMID: 20102431; eng.
   PubMed Web of Science ®Google Scholar
• Marai I, Gurevitz O, Carasso S, et al. Improvement of congestive heart failure by upgrading of conventional to resynchronization pacemakers. Pacing and clinical electrophysiology: PACE. 2006; Aug;29(8):880–884. PubMed PMID: 16923005; eng.
   PubMed Web of Science ®Google Scholar
• Witte KK, Pipes RR, Nanthakumar K, et al. Biventricular pacemaker upgrade in previously paced heart failure patients – improvements in ventricular dyssynchrony. J Card Fail. 2006; Apr;12(3):199–204. PubMed PMID: 16624685; eng.
   PubMed Web of Science ®Google Scholar
• Nagele H, Dodeck J, Behrens S, et al. Hemodynamics and prognosis after primary cardiac resynchronization system implantation compared to “upgrade” procedures. Pacing and clinical electrophysiology: PACE. 2008; Oct;31(10):1265–1271. PubMed PMID: 18811806; eng.
   PubMed Web of Science ®Google Scholar
• Wokhlu A, Rea RF, Asirvatham SJ, et al. Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival. Heart rhythm. 2009; Oct;6(10):1439–1447. PubMed PMID: 19717348; eng.
   PubMed Web of Science ®Google Scholar
• Frohlich G, Steffel J, Hurlimann D, et al. Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling. Eur Heart J. 2010; Jun;31(12):1477–1485. PubMed PMID: 20233792; eng.
   PubMed Web of Science ®Google Scholar
• Paparella G, Sciarra L, Capulzini L, et al. Long-term effects of upgrading to biventricular pacing: differences with cardiac resynchronization therapy as primary indication. Pacing and clinical electrophysiology: PACE. 2010; Jul;33(7):841–849. PubMed PMID: 20180916; eng.
   PubMed Web of Science ®Google Scholar
• Gage RM, Burns KV, Bank AJ. Echocardiographic and clinical response to cardiac resynchronization therapy in heart failure patients with and without previous right ventricular pacing. Eur J Heart Fail. 2014; Nov;16(11):1199–1205. . PubMed PMID: 25132044; eng.
   PubMed Web of Science ®Google Scholar
• Lipar L, Srivathsan K, Scott LR. Short-term outcome of cardiac resynchronization therapy – a comparison between newly implanted and chronically right ventricle-paced patients. Int J Cardiol. 2016; Sep;15;219:195–199.
   PubMed Web of Science ®Google Scholar
• Tayal B, Gorcsan J 3rd, Delgado-Montero A, et al. Comparative long-term outcomes after cardiac resynchronization therapy in right ventricular paced patients versus native wide left bundle branch block patients. Heart rhythm. 2016; Feb;13(2):511–518. PubMed PMID: 26545939; eng.
   PubMed Web of Science ®Google Scholar
• Shetty AK, Rinaldi CA. Cardiac resynchronization therapy upgrade: verschlimmbesserung? Circulation Arrhythmia and electrophysiology. 2017; Feb;10(2):e004956. PubMed PMID: 28202631; eng.
   PubMed Web of Science ®Google Scholar
• Merkely B, Kosztin A, Roka A, et al. Rationale and design of the BUDAPEST-CRT upgrade study: a prospective, randomized, multicentre clinical trial. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2017; Sep;1;19(9):1549–1555. PubMed PMID: 28339581; PubMed Central PMCID: PMCPMC5834067. eng.
   PubMed Web of Science ®Google Scholar
• Shetty AK, Duckett SG, Ginks MR, et al. Cardiac magnetic resonance-derived anatomy, scar, and dyssynchrony fused with fluoroscopy to guide LV lead placement in cardiac resynchronization therapy: a comparison with acute haemodynamic measures and echocardiographic reverse remodelling. Eur Heart J Cardiovasc Imaging. 2013; Jul;14(7):692–699. PubMed PMID: 23175695; eng.
   PubMed Web of Science ®Google Scholar
• Gould J, Behar J, Rajani R, et al. P333 Dual energy cardiac computed tomography to guide cardiac resynchronisation therapy: a feasibility study using coronary venous anatomy, scar and strain to guide optimal left ventricular lead placement. EP Europace. 2018;20(suppl_1):i53–i54.
   Google Scholar
• Reddy VY, Miller MA, Neuzil P, et al. Cardiac resynchronization therapy with wireless left ventricular endocardial pacing: the SELECT-LV study. J Am Coll Cardiol. 2017; May;02;69(17):2119–2129. PubMed PMID: 28449772; eng.
   PubMed Web of Science ®Google Scholar
• Morgan JM, Biffi M, Geller L, et al. ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy. Eur Heart J. 2016; Jul;14;37(27):2118–2127. PubMed PMID: 26787437; eng.
   PubMed Web of Science ®Google Scholar
• Sieniewicz B, Behar J, Gould J, et al. P329 Optimal site selection during biventircualar endocardial pacing improves acute haemodynamic response and chronic remodeling: a multi-centre UK study. EP Europace. 2018;20(suppl_1):i52–i52.
   Google Scholar
• Sieniewicz BJ, Behar JM, Sohal M, et al. Electrical latency predicts the optimal left ventricular endocardial pacing site: results from a multicentre international registry. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2018; Apr;23; PubMed PMID: 29688340; eng. DOI:10.1093/europace/euy052.
   Google Scholar
• Gamble JHP, Herring N, Ginks M, et al. Endocardial left ventricular pacing for cardiac resynchronization: systematic review and meta-analysis. Europace: European pacing, arrhythmias, cardiac electrophysiology: journal working groups cardiac pacing, arrhythmias, cardiac cellular electrophysiology European Society Cardiology. 2018; Jan;1;20(1):73–81. PubMed PMID: 28073886; eng.
   PubMed Web of Science ®Google Scholar